What I am missing.... [Regulatives / Guidelines]

posted by wienui  – Germany, Oman, 2020-03-29 09:26 (298 d 13:13 ago) – Posting: # 21307
Views: 1,124

Hi Captain,

» This is all about what Sponsors should do in this situation.
» Now, where's information on what regulators should do?

Very clever, you have turned the arrow!!! You are right, I totally agree with you, the jurisdictions bodies should circulate informations, assessment principles & rules how they will treated the conducted and submitted Clinical trials in Coronavirus situations.

» A negative scenario is if a trial is so affected by the Corona virus situation that regulators after submission will not be able to use the data to form a qualified decision whether positive or negative. In such cases, in hindsight, the trial should have been terminated for futulity.

Again, I agree with you.

» Therefore, I consider it of importance that we hear from regulators not just what they think Sponsors should do, but also what they think they should do.

I think you hope too much regarding this point. As I know, regulators prefer freezing all submissions in this time, let's wait and drink tea.


Complete thread:

 Admin contact
21,310 posts in 4,445 threads, 1,489 registered users;
online 3 (0 registered, 3 guests [including 1 identified bots]).
Forum time: Thursday 21:40 CET (Europe/Vienna)

Politicians use statistics like drunkards use lampposts:
not for illumination, but for support.    attributed to Hans Kuhn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz